298 related articles for article (PubMed ID: 20149763)
41. The application of statistical methods using VOCs to identify patients with lung cancer.
Ulanowska A; Kowalkowski T; Trawińska E; Buszewski B
J Breath Res; 2011 Dec; 5(4):046008. PubMed ID: 22071773
[TBL] [Abstract][Full Text] [Related]
42. Oxidative Stress Biomarkers in Exhaled Breath of Workers Exposed to Crystalline Silica Dust by SPME-GC-MS.
Jalali M; Zare Sakhvidi MJ; Bahrami A; Berijani N; Mahjub H
J Res Health Sci; 2016; 16(3):153-161. PubMed ID: 27840344
[TBL] [Abstract][Full Text] [Related]
43. New graphene fiber coating for volatile organic compounds analysis.
Zhang G; Guo X; Wang S; Wang X; Zhou Y; Xu H
J Chromatogr B Analyt Technol Biomed Life Sci; 2014 Oct; 969():128-31. PubMed ID: 25171504
[TBL] [Abstract][Full Text] [Related]
44. In situ detection of lung cancer volatile fingerprints using bronchoscopic air-sampling.
Santonico M; Lucantoni G; Pennazza G; Capuano R; Galluccio G; Roscioni C; La Delfa G; Consoli D; Martinelli E; Paolesse R; Di Natale C; D'Amico A
Lung Cancer; 2012 Jul; 77(1):46-50. PubMed ID: 22264635
[TBL] [Abstract][Full Text] [Related]
45. Headspace solid phase microextraction and gas chromatography-quadrupole mass spectrometry methodology for analysis of volatile compounds of marine salt as potential origin biomarkers.
Silva I; Rocha SM; Coimbra MA
Anal Chim Acta; 2009 Mar; 635(2):167-74. PubMed ID: 19216874
[TBL] [Abstract][Full Text] [Related]
46. Quantification of 31 volatile organic compounds in whole blood using solid-phase microextraction and gas chromatography-mass spectrometry.
Blount BC; Kobelski RJ; McElprang DO; Ashley DL; Morrow JC; Chambers DM; Cardinali FL
J Chromatogr B Analyt Technol Biomed Life Sci; 2006 Mar; 832(2):292-301. PubMed ID: 16495163
[TBL] [Abstract][Full Text] [Related]
47. Breath analysis by optical fiber sensor for the determination of exhaled organic compounds with a view to diagnostics.
Silva LI; Freitas AC; Rocha-Santos TA; Pereira ME; Duarte AC
Talanta; 2011 Feb; 83(5):1586-94. PubMed ID: 21238756
[TBL] [Abstract][Full Text] [Related]
48. Exhaled ERCC-1 and ERCC-2 microsatellite alterations in NSCLC patients.
Carpagnano GE; Palladino GP; Gramiccioni C; Foschino Barbaro MP; Martinelli D
Lung Cancer; 2010 May; 68(2):305-7. PubMed ID: 20188432
[TBL] [Abstract][Full Text] [Related]
49. Volatile composition of Brassica oleracea L. var. costata DC leaves using solid-phase microextraction and gas chromatography/ion trap mass spectrometry.
de Pinho PG; Valentão P; Gonçalves RF; Sousa C; Andrade PB
Rapid Commun Mass Spectrom; 2009 Aug; 23(15):2292-300. PubMed ID: 19579264
[TBL] [Abstract][Full Text] [Related]
50. Noninvasive detection of colorectal cancer by analysis of exhaled breath.
Wang C; Ke C; Wang X; Chi C; Guo L; Luo S; Guo Z; Xu G; Zhang F; Li E
Anal Bioanal Chem; 2014 Jul; 406(19):4757-63. PubMed ID: 24820062
[TBL] [Abstract][Full Text] [Related]
51. Noninvasive detection of lung cancer by analysis of exhaled breath.
Bajtarevic A; Ager C; Pienz M; Klieber M; Schwarz K; Ligor M; Ligor T; Filipiak W; Denz H; Fiegl M; Hilbe W; Weiss W; Lukas P; Jamnig H; Hackl M; Haidenberger A; Buszewski B; Miekisch W; Schubert J; Amann A
BMC Cancer; 2009 Sep; 9():348. PubMed ID: 19788722
[TBL] [Abstract][Full Text] [Related]
52. Breath analysis of smokers, non-smokers, and e-cigarette users.
Papaefstathiou E; Stylianou M; Andreou C; Agapiou A
J Chromatogr B Analyt Technol Biomed Life Sci; 2020 Dec; 1160():122349. PubMed ID: 32920481
[TBL] [Abstract][Full Text] [Related]
53. Confounding effect of benign pulmonary diseases in selecting volatile organic compounds as markers of lung cancer.
Wang M; Sheng J; Wu Q; Zou Y; Hu Y; Ying K; Wan H; Wang P
J Breath Res; 2018 Sep; 12(4):046013. PubMed ID: 30102249
[TBL] [Abstract][Full Text] [Related]
54. Characterization of volatile substances in apples from Rosaceae family by headspace solid-phase microextraction followed by GC-qMS.
Ferreira L; Perestrelo R; Caldeira M; Câmara JS
J Sep Sci; 2009 Jun; 32(11):1875-88. PubMed ID: 19425016
[TBL] [Abstract][Full Text] [Related]
55. Perylene diimide-POSS network for semi selective solid-phase microextraction of lung cancer biomarkers in exhaled breath.
Soufi G; Bagheri H; Yeganeh Rad L; Minaeian S
Anal Chim Acta; 2022 Mar; 1198():339550. PubMed ID: 35190135
[TBL] [Abstract][Full Text] [Related]
56. Development of an Exhaled Breath Monitoring System with Semiconductive Gas Sensors, a Gas Condenser Unit, and Gas Chromatograph Columns.
Itoh T; Miwa T; Tsuruta A; Akamatsu T; Izu N; Shin W; Park J; Hida T; Eda T; Setoguchi Y
Sensors (Basel); 2016 Nov; 16(11):. PubMed ID: 27834896
[TBL] [Abstract][Full Text] [Related]
57. Association of Smoking with Metabolic Volatile Organic Compounds in Exhaled Breath.
Chen X; Wang F; Lin L; Dong H; Huang F; Ghulam Muhammad K; Chen L; Gorlova OY
Int J Mol Sci; 2017 Oct; 18(11):. PubMed ID: 29068415
[TBL] [Abstract][Full Text] [Related]
58. Qualitative screening for volatile organic compounds in human blood using solid-phase microextraction and gas chromatography-mass spectrometry.
Gottzein AK; Musshoff F; Madea B
J Mass Spectrom; 2010 Apr; 45(4):391-7. PubMed ID: 20301087
[TBL] [Abstract][Full Text] [Related]
59. Respiratory symptoms and peak expiratory flow in children with asthma in relation to volatile organic compounds in exhaled breath and ambient air.
Delfino RJ; Gong H; Linn WS; Hu Y; Pellizzari ED
J Expo Anal Environ Epidemiol; 2003 Sep; 13(5):348-63. PubMed ID: 12973363
[TBL] [Abstract][Full Text] [Related]
60. Screening for emphysema via exhaled volatile organic compounds.
Cristescu SM; Gietema HA; Blanchet L; Kruitwagen CL; Munnik P; van Klaveren RJ; Lammers JW; Buydens L; Harren FJ; Zanen P
J Breath Res; 2011 Dec; 5(4):046009. PubMed ID: 22071870
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
